Revolution Medicines, Inc. (RVMD)
NMS – Real Time Price. Currency in USD
204.79
-0.76 (-0.37%)
Market open: Aug 12, 2026, 2:43 PM EDT
205.70
+0.15 (0.07%)
Previous after-hours: Aug 11, 2026, 7:58 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
204.79
-0.76 (-0.37%)
Market open: Aug 12, 2026, 2:43 PM EDT
205.70
+0.15 (0.07%)
Previous after-hours: Aug 11, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
Total debt $1.2B significantly exceeds cash reserves ($815.4M), raising financial stability concerns
Total current assets $4.0B exceed Total current liabilities $354.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.5) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-21.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$389.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.38 | 6.05 | 10 | |
| Quick ratio | 11.38 | 5.63 | 10 | |
| Debt to Equity | 0.46 | 0.30 | 7.0 | |
| Debt to Assets | 0.28 | 1.04 | 7.0 | |
| Interest coverage | -21.24 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 35M | 12M | N/A | N/A | N/A |
| Gross Profit | 26M | 2M | -12M | -17M | -18M |
| Operating Income | -258M | -487M | -690M | -1.18B | -1.63B |
| Net Income | -249M | -436M | -600M | -1.13B | -1.77B |
| EBITDA | -249M | -478M | -678M | -1.17B | -1.61B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -47.36 | 1.0 |
| Next quarter | N/A | -6.99 | 1.0 |
| Current year | N/A | -58.21 | 1.0 |
| Next year | 595.12 | 31.36 | 10 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -41.98 | -33.61 | -9.52 | 3.3 |
| Y/Y | 999 | -160.04 | -133.58 | -69.97 | 3.3 |
| 3y average | 277.25 | -67.15 | -28.07 | -57.22 | 3.3 |
| 5y average | 164.1 | -61.46 | -26.38 | -54.78 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Narrow | 2.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 2.0 |
| Weighted average score | 2.6 | |